Results of a survey of hospital-based radiology practice directors suggest the credit crunch that has accompanied the national recession does not appear to have promoted interest among hospital administrators in leasing as an option for obtaining new medical equipment.
Results of a survey of hospital-based radiology practice directors suggest the credit crunch that has accompanied the national recession does not appear to have promoted interest among hospital administrators in leasing as an option for obtaining new medical equipment.
According to the MarkeTech Group, which conducted the survey in June at the request of Diagnostic Imaging, more than half of 186 hospital-based radiology administrators responding to the survey said they were not at all or somewhat interested in leasing. More than a third said the bond market downturn would have no impact on their ability to finance projects and equipment purchases.
“The hospital market is very entrenched in a capital acquisition mentality,” said MarkeTech Group CEO Christian Renaudin, Ph.D. “They want to own their own equipment.”
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.